Katherine Bach Kalin serves as Executive at SELLAS Life Sciences Group, Inc., where they oversee executive responsibilities. Since joining the company, Katherine Bach Kalin has executed 3 insider transactions totaling $100.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 19, 2025 involved purchasing 63,400 shares valued at $100.8K.
Katherine Bach Kalin currently holds 104,400 shares of SELLAS Life Sciences Group, Inc. (SLS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Katherine Bach Kalin has been a net buyer of SLS stock. They have purchased $100.8K and sold $0 worth of shares.
Katherine Bach Kalin's most recent insider trade was on Nov 19, 2025, when they purchased 63,400 shares at $1.59 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 2, 2023 | SLS | $0 | Award | 2,500 | $N/A | Discretionary |